IMPLANTABLE TISSUE CONNECTOR

Abstract

An implantable tissue connector adapted so as to be connectable to a tubular part of living tissue within a patient's body, comprising: a conduit having at least a first end and a second end and further having an outer surface, wherein between the first and second ends of the conduit or connected to the second end of the conduit, there is provided at least one of the following items: a reservoir in the form of a fecal excrements collecting container or adapted to be filled with at least one medical drug for patient needs, a pump, a motor, a medical device of the following group of devices comprising: a drug delivery system, an artificial urine bladder, an artificial urethra, an artificial esophagus, an artificial trachea, and at least one flexible sleeve adapted to axially extend and closely fit around at least part of said outer surface of the conduit, wherein the tissue connector is adapted such that the tubular part of living tissue can be located and held in position between the conduit and the flexible sleeve.

Claims

1. (canceled)

101. An implantable tissue connector adapted so as to be connectable to a tubular part of living tissue within a patient's body, comprising: a conduit having at least a first end and a second end and further having an outer surface, wherein between the first and second ends of the conduit or connected to the second end of the conduit, there is provided at least one of the following items: a reservoir in the form of a fecal excrements collecting container or adapted to be filled with at least one medical drug for patient needs, a pump, a motor, a medical device of the following group of devices comprising: a drug delivery system, an artificial urine bladder, an artificial urethra, an artificial esophagus, an artificial trachea, and at least one flexible sleeve adapted to axially extend and closely fit around at least part of said outer surface of the conduit, wherein the tissue connector is adapted such that the tubular part of living tissue can be located and held in position between the conduit and the flexible sleeve.

102. The implantable tissue connector of claim 101, wherein the conduit is made from a biocompatible material, wherein the biocompatible material is preferably a material of the following group of materials comprising: titanium, stainless steel, ceramics, polytetrafluoroethylene (PTFE), expanded polytetrafluoroethylene (ePTFE), polyetheretherketone (PEEK), silicone, polyurethane, polypropylene, other biocompatible polymer material.

103. The implantable tissue connector of claim 101, wherein said flexible sleeve is mounted on said outer surface either folded or rolled upon itself or so as to be foldable upon itself, wherein, where the flexible sleeve is mounted on the outer surface of the conduit so as to be foldable upon itself, the flexible sleeve, when folded upon itself, will exert radial pressure.

104. The implantable tissue connector of claim 101, said flexible sleeve is mounted on said outer surface either folded or rolled upon itself or so as to be foldable upon itself, wherein, where the flexible sleeve is mounted on the outer surface of the conduit folded or rolled upon itself, the flexible sleeve, when unfolded or unrolled, will exert radial pressure.

105. The implantable tissue connector of claim 104, wherein, when implanted in a patient's body with the sleeve unfolded or unrolled, the tissue connector is adapted to exert said radial pressure on any living tubular tissue placed intermediate the sleeve and the outer surface of the conduit.

106. The implantable tissue connector of claim 101, wherein the conduit is less flexible than the flexible sleeve at least in a radial direction so as to provide support to the sleeve against radial forces.

107. The implantable tissue connecter of claim 101, wherein the conduit and the flexible sleeve are fixedly connected to each other along an axially extending portion of the sleeve.

108. The implantable tissue connector of claim 107, wherein the conduit and the flexible sleeve are bonded along at least part of said axially extending portion of the, wherein preferably the tissue connector comprises a primer on at least one of the conduit and the flexible sleeve to enhance bonding characteristics.

109. The implantable tissue connector of claim 101, wherein the at least one flexible sleeve is located proximately to said first end of the conduit.

110. The implantable tissue connector of claim 101, wherein the conduit has at least two of said flexible sleeves, wherein preferably the at least two flexible sleeves are each located proximately to one of said at least first and second ends of the conduit.

111. The implantable tissue connector of claim 101, wherein the first end of the conduit has a free end portion and tapers towards the edge of said free end portion.

112. The implantable tissue connector of claim 101, wherein the first end of the conduit has a free end portion with a rounded edge.

113. The implantable tissue connector of claim 101, wherein the conduit has an inner diameter of between 0.1 and 0.5 cm or between 0.5 and 1 cm or between 1 and 2 cm or between 2 and 3 cm or between 3 and 4 cm, or, an inner diameter of 4 cm or over.

114. The implantable tissue connector of claim 101, wherein said conduit is sized so as to be snuggly fitted into a human's esophagus.

115. The implantable tissue connector of claim 101, wherein said conduit is sized so as to be snuggly fitted into a human's trachea.

116. The implantable tissue connector of claim 101, wherein said conduit is sized so as to be snuggly fitted into a human's stomach.

117. The implantable tissue connector of claim 101, wherein said conduit is sized so as to be snuggly fitted into a human's gall bladder or its connecting outlet channels.

118. The implntable tissue connector of claim 101, wherein said conduit is sized so as to be snuggly fitted into a human's small bowel or large bowel.

119. The implantable tissue connector of claim 101, wherein said conduit is sized so as to be snuggly fitted into a human's urethra or ureter.

120. The implantable tissue connector of claim 101, wherein said conduit is sized so as to be snuggly fitted into a human's pelvic part of the kidney.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

[0059] FIG. 1 shows an examplary view of a patient with one tissue connector connected to the patient's aorta and another tissue connector connected to the end of the patient's large bowel.

[0060] FIGS. 2a and 2b show a cross-section of a first embodiment of the tissue connector in the state of mounting and in the connected state.

[0061] FIGS. 3a and 3b show a cross-section of an alternative of the first embodiment of the tissue connector in the state of mounting and in the connected state.

[0062] FIGS. 4a and 4b show a second embodiment of the tissue connector in the state mounting and in the connected state.

[0063] FIG. 5 shows an alternative for mounting living tissue on a free end of the tissue connector.

[0064] FIGS. 6a and 6b show a combination of an embodiment similar to the one shown in FIGS. 2a and 2b with additional mounting means as shown in FIG. 5.

[0065] FIG. 7 shows a specific embodiment of a tissue connector with two ends thereof connected to living tissue.

[0066] FIG. 1 schematically shows a body 100 of a patient with a first tissue connector 1 connected to the end of the patient's large bowel 50 and a second tissue connector 1a interconnecting two pieces of the patient's aorta 60. The tissue connector 1 may either connect the large bowel 50 to the patient's anus or to an artificial anus which may include an excrements collecting container. The tissue connector 1a may include between its two ends a heart valve, a blood pump, a drug delivery device or the like.

[0067] The tissue connectors 1 and 1a shown in FIG. 1 represent only a few of many different possible locations and applications of the tissue connector within the human's or, alternatively, an animal's body. Further examples of possible applications have already been outlined further above.

[0068] FIGS. 2a and 2b show a first embodiment of the tissue connector 1 in the state of mounting the tissue connector to a tubular part of living tissue 70. The tissue connector 1 comprises a conduit 2 with a first end 3 and a second end 4. In FIG. 2a, the first end 3 of the conduit 2 has already been inserted into an end portion of living tissue 70. The inner cross section of the conduit 2 is selected to approximately match the inner cross section of the tubular living tissue 70 so as not to obstruct any flow of material. The thickness of the wall 5 of the conduit, which is typically circular, is chosen to provide sufficient strength so that it does not collapse under the forces that will act upon the conduit during use, while providing sufficient flexibility where needed. On the other hand, the thickness should not be chosen too large since the living tissue will have to be stretched over the outer surface 6 of the conduit 2 without damage and without excessively affecting blood circulation within the end portion 71 of the living tissue 70.

[0069] The wall 5 of conduit 2 is tapered towards its leading edge 7. In addition, the leading edge 7 is rounded. These two measures prevent damage to the living tissue 70 when the conduit 2 is inserted into the end portion 71 of the living tissue 70.

[0070] The second end 4 may serve and be adapted to be connected to an implantable medical device, an implantable reservoir, an implantable pump, an implantable motor or a combination of the afore mentioned items (generally designated with 200). It may also be connected to any other implantable device 200. The implantable device 200 may even form a part of the tissue connector 1, either integrally or attached thereto.

[0071] The implantable device 200 may also be a medical device replacing one or more of the patient's organs, such as an artificial urine bladder, a fecal excrement's collecting container, an artificial urethra, an artificial heart, an artificial esophagus, an artificial trachea or the like. Alternatively, the second end 4 of the conduit 2 may be connected to a biological implant obtained from a third party's body, such as a urine bladder, an intestine, a urethra, a ureter, a kidney, a bowel, a heart, an esophagus, a trachea, a blood vessel or the like.

[0072] The device 200 may also comprise a flow restrictor for partial or complete restriction of flow through the conduit. This can be suitable e.g. in the case where the tissue connector is located at the end of the patient's large bowel.

[0073] The device 200 may also be placed between the tissue connector 1 and a second tissue connector 1b with conduit 2b, as is indicated in FIG. 2a by dotted lines. This arrangement is practical where the device 200 has to be placed at a location within one of the patient's organs, such as in a blood vessel, in which case the blood vessel would be divided and the device 200 placed between the two tissue connectors 1 and 1b connected to the respective free ends of the divided blood vessel. As an example, the device 200 could include a flow restrictor, such as an artificial heart valve, or a drug delivery reservoir.

[0074] Apart from the conduit 2 and the optional device 200, the tissue connector 1 of the embodiment shown in FIG. 2a has a flexible sleeve 10 axially extending and closely fitted around a part of the outer surface 6 of the conduit 2. The flexible sleeve 10 may be delivered separately from the conduit 2 and placed over the conduit's outer surface 6 shortly before implantation into the patient's body. However, it is preferred to provide the conduit 2 with the flexible sleeve 10 as a unitary item, the flexible sleeve 10 preferably fixed to the outer surface 6 by means of bonding, welding and/or clamping. In the case of bonding, it can be advisable to pretreat the outer surface 6 e.g. with a primer, depending upon the material combination to be bonded together.

[0075] In FIG. 2a, the flexible sleeve 10 is rolled upon itself and can be unrolled over the portion 71 of living tissue 70 so as to cover, seal and protect that portion 71 on the first end 3 of the conduit 2, as is shown in FIG. 2b. The tissue portion 71 and the overlapping part 11 of flexible sleeve 10 are fixed to the first end 3 of the conduit 2 by suturing threads 20 therethrough and through the wall 5 of the conduit 2, as is indicated in FIG. 2b by dotted lines.

[0076] The flexible sleeve 10 is a multilayer material comprising a porous ingrowth layer to allow ingrowth of living tissue. For that, it has a netlike structure. On top of the ingrowth layer 11 there is provided a support layer 12. The support layer 12 may have one ore more of various functions. One possible function is to provide support to the ingrowth layer 11 so as to ease handling and/or prevent fussing of the ingrowth layer. Also, the support layer 12 may provide some tension, thereby exerting a compressive force in a radial direction so as to slightly clamp the tissue portion 71 against the outer surface 6 of the conduit 2. For that, the support layer should have an appropriate elasticity. Finally, the support layer may provide protection for the tissue portion 71.

[0077] Preferably, the support layer should be porous so that exchange between the tissue portion 71 and the surrounding area within the patient's body is possible. This is an important aspect for the ingrowth of living tissue material into the ingrowth layer 11. Expanded polytetrafluoroethylene (ePTFE) is particularly suitable, as it is flexible, inert and can be made with any desired porosity. Other biocompatible polymers, such as polyurethane and the like, are suitable as well.

[0078] FIGS. 3a and 3b show an alternative of the first embodiment of the tissue connector which differs from the connector shown in FIGS. 2a and 2b solely by the fact that the flexible sleeve 10 is not rolled upon itself but, instead, folded upon itself. By unfolding the folded sleeve 10, it can be placed over the tissue portion 71 in the same manner as discussed above in relation to FIGS. 2a, 2b, as is shown in FIG. 3b.

[0079] FIGS. 4a and 4b show a second embodiment of a tissue connector where the flexible sleeve 10 is arranged such that it is foldable upon itself. More particularly, the first end 3 of the conduit 2 is inserted in the tissue portion 71 of living tissue 70 to an extent that it overlaps a first portion 13 of the flexible sleeve 10. The remaining portion 14 of the flexible sleeve 10 not being covered by the tissue portion 71 is rolled upon itself and can be unrolled so as to cover the tissue portion 71. As a result shown in FIG. 4b, the flexible sleeve 10 is folded upon itself with the tissue portion 71 placed intermediate the folded sleeve 10.

[0080] Different to the embodiments described before, suturing the tissue portion 71 to the wall 5 of the conduit 2 is carried out before the tissue portion 71 is covered with the remaining part 14 of the flexible sleeve 10. The remaining part 14 thereby seals any penetration holes caused by the suturing.

[0081] In an alternative of the second embodiment, not shown, the first end 3 of the conduit 2 will be inserted in the tissue portion 71 only so far that the tissue portion 71 does not overlap with the flexible sleeve 10. Thus, after unrolling the flexible sleeve 10, only a part of the folded sleeve 10 will cover the tissue portion 71.

[0082] Furthermore, also not shown, the remaining part 14 of the sleeve 10 is not necessarily rolled upon itself, as shown in FIG. 4a, but may lay flat against the outer surface 6 of the conduit 2, similar to the embodiment shown in FIG. 3a.

[0083] As will be recognized, the portion 13 of the flexible sleeve 10 is arranged in a circumferential groove provided in the outer surface 6 of the conduit 2. It is advantageous when the depth of the groove corresponds to the thickness of the flexible sleeve 10. This will facilitate introducing the first end 3 of the conduit 2 into the living tissue 70.

[0084] FIG. 5 shows a possibility of fixing the conduit 2, such as the conduit's second end 4, to a tubular part of living tissue 80 or to a hose that belongs or leads to a medical device, reservoir, or the like. Accordingly, at least one bulge 15 extends outwardly from the conduit's outer surface 6 in a circumferential direction of the conduit 2 about at least a part of the conduit's circumference. Furthermore, at least one blocking ring 30 loosely fitting over the outer surface 6 of the conduit 2 with a clearance between the outer surface 6 and the blocking ring 30 is provided for mounting the tubular living tissue 80 (or alternatively the hose) within the clearance. The blocking ring has an inner cross-sectional diameter which is about the same as the outer cross-sectional diameter of the bulge 15. This prevents the blocking ring from slipping over the bulge when the living tissue 80, as shown in FIG. 5, is mounted within the clearance.

[0085] When an axial force tends to pull the tubular living tissue 80 from the outer surface 6 of the conduit 2, the blocking ring 30 will move with the tubular tissue 80, thereby compressing the tubular tissue 80 against the bulge 15, so as to prevent any further slippage of the tubular tissue 80 over the bulge 15. This is a self-enhancing effect.

[0086] This kind of locking mechanism can be combined with any of the aforementioned embodiments of the tissue connector. Of these variants, only one shall examplary be described in the following in relation to FIGS. 6a and 6b. The embodiment shown in FIGS. 6a and 6b substantially correspond to the embodiment of FIGS. 2a and 2b, where the flexible sleeve 10 is rolled upon itself and then unrolled to cover the tubular tissue 80 which, in this case, is pulled over the second end 4 of the conduit 2 sufficiently far so as to extend also over the bulge 15. After the flexible sleeve 10 has been unrolled over the tubular tissue 80, the blocking ring 30 is pushed over the flexible sleeve against the bulge 15. After a while, the threads 20 sutured to the tubular tissue 80 and the wall 5 of the conduit 2 (FIG. 6a) will have been absorbed by the patient's body and, about during the same time, living tissue will have formed in and connect the tubular tissue 80 to the ingrowth layer 11 of the flexible sleeve 10. Therefore, as the tubular tissue 80 tends to be pulled off of the second end 4 of the conduit 2, the blocking ring 30 will also be moved, press the tubular tissue 80 and the flexible sleeve 10 against the bulge 15 and thereby prohibit any further slippage of the tubular tissue 80 over the bulge 15. The friction coefficient between the blocking ring 30 and the outer surface of the flexible sleeve should be higher than the friction coefficient which the conduit's outer surface 6 has in relation to the tubular tissue 80.

[0087] Note that the flexible sleeve 10 in its unrolled state as shown in FIG. 6b must not necessarily extend over the bulge 15 but can end a distance away from the bulge. In that situation, the blocking ring 30 would not clamp the sleeve 10 against the bulge 15.

[0088] The afore mentioned embodiments have mainly been described in relation to a tissue connector of which only one of the two ends is intended to be connected to tubular living tissue. However, as has also been mentioned before, there are various applications where the tissue connector may connect two pieces of tubular living tissue, such as when bridging two pieces of identical tubular living tissue or connecting tubular living tissue with tissue of a biological transplant. For that, the second end 4 of the tissue connector's conduit 2 can be designed according to any of the aforementioned embodiments. FIG. 7 gives just an example of how such tissue connector could be designed. Accordingly, two flexible sleeves 10 are integrally formed to form a single flexible sleeve 10a, with each of the sleeves 10 being rolled upon itself, similar to the embodiment shown in FIG. 2a. The two flexible sleeves 10 can, of course, be provided separately. Furthermore, a bulge 15 and a blocking ring 30 can be provided at one or both of the conduit's ends 3 and 4. Also, a medical device, flow restrictor or the like can be incorporated intermediate the two ends 3 and 4.